Evaluation of a Universal Nested Reverse Transcription Polymerase Chain Reaction for the Detection of Lyssaviruses
May 2nd, 2019
8K views
A pan-lyssavirus nested reverse transcription polymerase chain reaction has been developed to detect specifically all known lyssaviruses. Validation using rabies brain samples of different animal species showed that this method has a sensitivity and specificity equivalent to the gold standard fluorescent antibody test and could be used for routine rabies diagnosis.
Overview
A pan-lyssavirus nested reverse transcription polymerase chain reaction (RT-PCR) has been developed to detect all known lyssaviruses. This method has shown high sensitivity and specificity, making it suitable for routine rabies diagnosis.
Key Study Components
Area of Science
- Virology
- Diagnostic methods
- Infectious diseases
Background
- Lyssaviruses include rabies and other related viruses.
- Traditional methods for rabies diagnosis can be time-consuming and require specialized equipment.
- There is a need for rapid and reliable diagnostic techniques.
- The nested RT-PCR method aims to address these challenges.
Purpose of Study
- To develop a sensitive and specific method for detecting lyssaviruses.
- To validate the method using a large number of animal brain specimens.
- To assess the method's applicability to various biological fluids.
Methods Used
- Nested RT-PCR technique for lyssavirus detection.
- Validation with over 9000 animal brain specimens.
- Testing on both fresh and degraded samples.
- Application to biological fluids such as cerebrospinal fluid, saliva, and urine.
Main Results
- The nested RT-PCR demonstrated high sensitivity and specificity.
- Results were comparable to the gold standard fluorescent antibody test.
- The method is effective for both fresh and degraded samples.
- It can be utilized for routine rabies diagnosis in clinical settings.
Conclusions
- The nested RT-PCR is a reliable method for detecting lyssaviruses.
- This technique can enhance rabies surveillance and diagnosis.
- Future applications may include broader use in various biological specimens.
Frequently Asked Questions
What is the significance of the nested RT-PCR method?
It provides a sensitive and specific way to detect all known lyssaviruses, improving rabies diagnosis.
How was the method validated?
The method was validated using over 9000 animal brain specimens collected over 10 years.
Can this method be used on degraded samples?
Yes, the nested RT-PCR can produce credible results on both fresh and degraded samples.
What types of biological fluids can be tested?
The method can be applied to cerebrospinal fluid, saliva, and urine.
What precautions should be taken during the PCR process?
It's important to prepare negative and positive controls and operate in physically separate areas to minimize contamination.
How does this method compare to traditional diagnostic methods?
It offers comparable sensitivity and specificity to the gold standard fluorescent antibody test, but is faster and more versatile.
Executive Industry Relevance
The universal nested RT-PCR method enables broad-spectrum detection of lyssaviruses, supporting early target validation in antiviral discovery programs. Its high sensitivity and specificity provide predictive confidence for de-risking lyssavirus-targeted therapeutic hypotheses. The method’s applicability to degraded samples and biological fluids enhances translational continuity from discovery to preclinical evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses across all known lyssavirus species, including novel variants.
- Operational Value: Provides functional target validation through detection of conserved nucleoprotein gene expression.
- Predictive Value: Supports portfolio triage by confirming pan-lyssavirus activity of candidate antivirals.
Screening & Assay Development
- Scientific Value: Delivers quantitative, reproducible amplification of lyssavirus N gene for assay standardization.
- Operational Value: Enables screening readiness across fresh and degraded sample types, improving workflow flexibility.
- Scalability: Compatible with high-throughput formats due to nested PCR design and internal controls.
Translational & Preclinical Research
- Disease Relevance: Detects lyssaviruses in cerebrospinal fluid, saliva, and urine, supporting biomarker-aligned preclinical models.
- Translational Continuity: Bridges discovery findings to preclinical validation using clinically relevant specimen types.
- Risk-Adjusted Advancement: Reduces false-negative risk in efficacy studies through 100% sensitivity across genetic clades.
Pipeline & Workflow Integration
The method fits within the antiviral discovery continuum from target validation through lead identification to preclinical efficacy testing.
- Discovery Biology: Supports mechanistic de-risking by confirming on-target activity across lyssavirus diversity.
- Screening: Enables reproducible, quantitative readouts for compound screening in BSL-2/3 environments.
- Analytics: Generates specific 371 bp amplicon readout for gel- or probe-based quantification across conditions.
- Translational Research: Aligns with biomarker strategies by detecting viral RNA in accessible biological fluids.
- Enterprise Reuse: Establishes a standardized lyssavirus detection platform for reuse across antiviral programs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in lyssavirus-targeted studies through universal detection.
- Operational Value: Ensures reproducibility via standardized controls and separation of pre-/post-PCR workflows.
- Strategic Value: Improves go/no-go decisions by minimizing biological false negatives in efficacy assays.
- Portfolio Impact: Enables risk-adjusted prioritization of lyssavirus-targeted candidates with confirmed cross-species reactivity.
Implementation Considerations
- Requires expertise in molecular virology and RT-PCR techniques.
- Needs thermocycler, gel electrophoresis, and UV documentation equipment.
- Demands physical separation of RNA extraction, PCR setup, and analysis areas to prevent contamination.
- Requires adaptation of controls when applied to non-neural specimen types like saliva or CSF.
- Limited by primer-template mismatches affecting sensitivity across highly divergent lyssavirus strains.
Biopharma FAQs
Why does nested RT-PCR matter for lyssavirus target validation?
It enables detection of all 18 lyssavirus species, including novel variants, confirming broad-spectrum target engagement. This supports mechanistic de-risking by verifying on-target activity across genetic clades. The method’s 100% sensitivity reduces false negatives in target validation assays.
How does independent variable isolation fit the antiviral discovery pipeline?
By using RNA extracts from infected cultures or specimens as the independent variable, the method isolates viral lyssavirus signal. This allows assessment of dependent variables like compound efficacy without host nucleic acid interference. The nested design enhances specificity for low-abundance targets in early screening.
What quantitative dependent variable measurements does nested RT-PCR enable?
The method produces a specific 371 bp amplicon whose presence/absence or intensity can be quantified via gel imaging or qPCR adaptation. This enables comparison of viral load across treatment conditions or time points. Quantitative output supports dose-response modeling and IC50 determination in lead optimization.
Why do replication requirements matter for cross-functional collaboration?
The method’s validation across 10 laboratories with 100% concordance to FAT ensures reproducible results across sites. This reproducibility supports technology transfer between discovery, preclinical, and clinical teams. Standardized controls and separation of workflows minimize variability in multi-site studies.
What statistical analysis capabilities are required before implementing nested RT-PCR?
Implementation requires capability to calculate sensitivity, specificity, and concordance relative to gold-standard methods. Teams must establish limits of detection using serial dilutions of viral RNA or plasmids. Statistical comparison of amplicon intensity across conditions enables robust efficacy assessment.
Chapters in this video
0:04
Title
1:37
RNA Extraction and Reverse Transcription of the Viral RNA
3:08
First-round PCR
4:03
Second-round PCR
4:41
Analysis of the PCR Products by Electrophoresis on Agarose Gels
5:48
Results: Evaluation of the Reverse Transcription Polymerase Chain Reaction for the Detection of Lyssaviruses
7:44
Conclusion
